Inventor
BROWN S DAVID
US14 patents
⚠️ This page may combine multiple inventors who share the name “BROWN S DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
EXELIXIS INC
5 patentsUS7989622B2Aug 2, 2011
Phosphatidylinositol 3-kinase inhibitors and methods of their use
EXELIXIS INC64 citations97
US8053454B2Nov 8, 2011
Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3
EXELIXIS INC4 citations62
US8013156B2Sep 6, 2011
Tie-2 modulators and methods of use
EXELIXIS INC4 citations60
US7498358B2Mar 3, 2009
Human ADAM-10 inhibitors
EXELIXIS INC2 citations60
US7951972B2May 31, 2011
Human adam-10 inhibitors
EXELIXIS INC0 citations49
MEI PHARMA INC
5 patentsUS10603324B2Mar 31, 2020
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
MEI PHARMA INC5 citations83
US10335415B2Jul 2, 2019
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
MEI PHARMA INC6 citations83
US10064868B2Sep 4, 2018
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
MEI PHARMA INC7 citations83
US11400097B2Aug 2, 2022
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
MEI PHARMA INC2 citations72
US12059422B2Aug 13, 2024
(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
MEI PHARMA INC0 citations62